NASDAQ$OSUR
OraSure Technologies Inc · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
Reported record revenue and positive cash flow from operations.
OraSure Technologies reported record revenue of $116.5 million for Q3 2022, a 116% increase year-over-year, driven by InteliSwab® revenue growth. The company achieved GAAP EPS of $0.07 and non-GAAP EPS of $0.13, and generated positive cash flow from operations ahead of prior guidance.
- Net revenues for the third quarter of 2022 were $116.5 million, a 116% increase from the third quarter of 2021 and a new record for the Company.
- Total InteliSwab® test revenue of $79.6 million increased 85% sequentially as the company scaled its production capacity and saw increased order volume supporting the Federal government’s school testing program.
- Core diagnostic revenue increased 14% versus the prior year primarily due to the contribution from non-product revenue strength which complements domestic HIV sales and international HCV sales. Core Molecular Solutions revenue decreased 24% year-over-year predominantly due to lower order volumes at more consumer-oriented accounts.
- GAAP operating income in the third quarter was $0.9 million which compares to a ($13.0) million operating loss in the third quarter of 2021. Non-GAAP operating income was $11.4 million in the quarter, increased by $12.7 million on a sequential basis.
Headline financials
Revenue & EPS history
OraSure · Revenue · Quarterly
$116M
Forward guidance
The Company is guiding toward 4Q22 revenue of $95 to $100 million representing 49% to 57% growth relative to the fourth quarter of last year. The Company is also guiding to continued positive cash flow from operations in the fourth quarter.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2022
-2.1%
Avg return
Earnings day
+0.4%
Avg return
5 days after
-2.4%
Avg return
30 days after
39%
25 / 64 earnings
Positive
+31.7%
Q2 2023
Best reaction
-32.1%
Q2 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.2% | -2.9% | — | |
| Q4 2025 | +10.0% | +6.4% | +7.1% | |
| Q3 2025 | -6.6% | -4.3% | -3.1% | |
| Q1 2025 | -6.8% | -5.0% | +3.6% | |
| Q4 2024 | -23.5% | -10.8% | -14.2% | |
| Q3 2024 | -1.2% | -1.2% | -8.9% | |
| Q2 2024 | +2.6% | -0.2% | +5.7% | |
| Q1 2024 | -8.8% | -6.9% | -15.3% | |
| Q4 2023 | +10.3% | +3.7% | -12.3% | |
| Q3 2023 | +4.9% | +14.5% | +22.2% | |
| Q2 2023 | +31.7% | +43.9% | +42.8% | |
| Q1 2023 | +9.2% | -20.8% | -22.3% | |
| Q4 2022 | +10.4% | +18.8% | +30.1% | |
| Q3 2022 | +0.7% | +20.8% | +18.5% | |
| Q2 2022 | +28.3% | +38.6% | +18.8% | |
| Q1 2022 | -8.9% | -3.9% | -48.8% | |
| Q4 2021 | -1.3% | -0.8% | -13.0% | |
| Q3 2021 | -4.9% | -7.7% | -19.8% | |
| Q2 2021 | +1.2% | -0.7% | -4.1% | |
| Q1 2021 | +5.0% | +5.1% | +0.2% | |
| Q4 2020 | -2.3% | +2.1% | +1.5% | |
| Q3 2020 | -15.6% | -15.4% | -20.6% | |
| Q2 2020 | -32.1% | -24.6% | -46.9% | |
| Q1 2020 | +6.1% | +15.6% | -33.1% | |
| Q4 2019 | -6.7% | -6.1% | +8.5% | |
| Q3 2019 | -3.1% | -6.9% | -10.3% | |
| Q2 2019 | -3.3% | -5.2% | -14.4% | |
| Q1 2019 | -8.0% | -12.6% | -12.7% | |
| Q4 2018 | -25.5% | -18.3% | -14.8% | |
| Q3 2018 | -8.7% | -6.6% | -15.0% | |
| Q2 2018 | -0.6% | -1.0% | -5.8% | |
| Q1 2018 | -15.4% | -11.0% | -2.4% | |
| Q4 2017 | -12.8% | -13.4% | -9.5% | |
| Q3 2017 | -30.3% | -26.6% | -13.8% | |
| Q2 2017 | +13.5% | +19.4% | +17.4% | |
| Q1 2017 | +16.9% | +10.9% | +17.6% | |
| Q4 2016 | +18.9% | +18.9% | +29.9% | |
| Q3 2016 | -0.1% | +1.4% | +14.3% | |
| Q2 2016 | +4.6% | +8.5% | +30.7% | |
| Q1 2016 | -6.6% | — | — | |
| Q4 2015 | +14.7% | — | — | |
| Q3 2015 | +0.4% | — | — | |
| Q2 2015 | +7.0% | — | — | |
| Q1 2015 | -12.3% | — | — | |
| Q4 2014 | -11.9% | — | — | |
| Q3 2014 | +2.9% | — | — | |
| Q2 2014 | -7.7% | — | — | |
| Q1 2014 | -9.2% | — | — | |
| Q4 2013 | +9.5% | — | — | |
| Q3 2013 | -0.3% | — | — | |
| Q2 2013 | +10.2% | — | — | |
| Q1 2013 | -0.4% | — | — | |
| Q4 2012 | -12.4% | — | — | |
| Q3 2012 | -16.4% | — | — | |
| Q2 2012 | -7.1% | — | — | |
| Q1 2011 | +5.0% | — | — | |
| Q1 2012 | -5.9% | — | — | |
| Q4 2011 | +4.6% | — | — | |
| Q3 2011 | -5.6% | — | — | |
| Q4 2010 | -12.5% | — | — | |
| Q2 2011 | -12.5% | — | — | |
| Q3 2010 | +6.6% | — | — | |
| Q2 2010 | -7.0% | — | — | |
| Q1 2010 | -15.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro